| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 5 | |
| #2 | EPO (European Patent Office) | 2 | |
| #3 | Australia | 1 | |
| #4 | Brazil | 1 | |
| #5 | Canada | 1 | |
| #6 | China | 1 | |
| #7 | Hong Kong | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Mexico | 1 | |
| #10 | New Zealand | 1 | |
| #11 | United States | 1 | |
| #12 | WIPO (World Intellectual Property Organization) | 1 | |
| #13 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Organic fine chemistry | |
| #2 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Harris Clifford John | 13 |
| #2 | Palmer Nicholas John | 13 |
| #3 | Mitchell Dale Robert | 13 |
| #4 | Goldsmith Michael Daniel | 13 |
| #5 | Macleod Angus | 13 |
| #6 | Parsy Christophe Claude | 13 |
| Publication | Filing date | Title |
|---|---|---|
| GB201218486D0 | Novel selective bromodomains inhibitors for the treatment of inflammation,cancer and viral infections | |
| GB201218485D0 | Novel selective bromodomains inhibitors for the treatment of inflamation, cancer and viral infections | |
| GB201218281D0 | Novel selective bromodomains inhibitors for the treatment of inflammation, cancer and viral infections | |
| GB201218282D0 | Novel selective bromodomains inhibitors for the treatment of inflammation, cancer and viral infections | |
| GB0716292D0 | Imidazopyrazine compounds |